News

The U.S. military is interested in ‘super spiders’ capable of producing silk with extraordinary features. Don’t worry—it ...
Researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth - paving the way for ...
Crispr-Cas9 is a tool for making precise edits in DNA, discovered in bacteria. The acronym stands for 'Clustered Regularly ...
Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she ...
For years, the CRISPR-Cas9 genome technology has been reshaping genetic engineering, a precision tool to transform everything ...
Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...
The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...
Interference No. 106,115 was the second interference between UC and Broad over patent rights to CRISPR-Cas9 technology in eukaryotic cells. The first interference concluded in 2018 after an appeal ...
This greatly increases the versatility of CRISPR/Cas9 while keeping the system simple and accessible. It also means that legacy gRNA libraries and standard Cas9 tools can be used more effectively ...
A favorable appeals court ruling repositioned a coalition of universities and Nobel laureates to win credit for inventing a ...
CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges. Learn why CRSP stock is a buy.